The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The classification of Swine Vaccines includes CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines and Other Vaccines. The proportion of T CSF Vaccines in 2017 is about 44%.
The global Swine Vaccines market was valued at US$ 1277.6 million in 2019 and is expected to reach US$ 1686.4 million by the end of 2026, growing at a CAGR of 4.0% during 2021-2026.
This report focuses on Swine Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Swine Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Swine Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Other
Segment by Application
Government Tender
Market Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The classification of Swine Vaccines includes CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines and Other Vaccines. The proportion of T CSF Vaccines in 2017 is about 44%.
The global Swine Vaccines market was valued at US$ 1277.6 million in 2019 and is expected to reach US$ 1686.4 million by the end of 2026, growing at a CAGR of 4.0% during 2021-2026.
This report focuses on Swine Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Swine Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Swine Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Other
Segment by Application
Government Tender
Market Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.